@article{acbca7ee9abd4aef93fcbe465615f37d,
title = "Correction: PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer(PLoS ONE (2019)8:1(e53292) Doi:10.1371/journal.pone.0053292)",
abstract = "The following information is missing from the Competing Interests statement: JB is a consultant to Novartis, Roche, Merck, Sanofi-Aventis, Verastem, Bayer, Chugai, Exelixis, Onyx and Constellation.",
author = "Sherene Loi and Stefan Michiels and Jose Baselga and Bartlett, {John M.S.} and Singhal, {Sandeep K.} and Sabine, {Vicky S.} and Sims, {Andrew H.} and Tarek Sahmoud and {Michael Dixon}, J. and Piccart, {Martine J.} and Christos Sotiriou",
note = "Publisher Copyright: {\textcopyright} 2019 Loi et al.",
year = "2019",
month = apr,
day = "1",
doi = "10.1371/journal.pone.0216175",
language = "English",
volume = "14",
journal = "PLoS ONE",
issn = "1932-6203",
number = "4",
}